Selection of a TIPS stent for management of portal hypertension in liver cirrhosis: An evidence-based review

Table 4 Outcome of transjugular intrahepatic portosystemic shunt with covered stents: An overview of case series

Ref.	Period	n	Indication for TIPS	Liver function	Follow-up time1	Patients with shunt dysfunction (n)	Cumulative shunt dysfunction or patency rate	HE (n)	No. Pts death (n)
Sajja et al[70]	2001.1- 2011.12	59	Ascites (16), variceal bleeding (31), both (12)	MELD score: 12.5	654 ± 341 (253-1584) d	6-mo: 8; overall: 14	NA	15	7
Wu et al[71]	NA	114	Pure esophageal variceal disruption hemorrhage (92), pure refractory cirrhotic ascites (8), esophageal variceal disruption hemorrhage with refractory ascites (14)	CPC A/B/C: 29/68/34	NA	16	1-yr dysfunction rate: 13.3%; 2-yr dysfunction rate: 24.8%	23	NA
Wu et al[72]	2008.1- 2011.12	150	Gastroesophageal variceal bleeding (134), refractory ascites (16)	CPC A/B/C: 30/81/39	24.1 ± 8.8 mo	17	NA	23	18
Rössle et al[73]	2000.4-2004.10	100	Variceal bleeding (41); refractory ascites, hydrothorax, or hepatorenal syndrome (59)	CPC A/B/C: 21/58/21	22 ± 15 (0.8-47) mo	6-mo: 6; 1-yr: 7; 2-yr: 11; overall: 16	NA	NA	22
Vignali et al[74]	2001.2-2003.12	114	Variceal bleeding (49), refractory ascites (52), hypertensive gastropathy (10), BCS (1), hepatorenal syndrome (2)	CPC A/B/C: 8/60/46	11.9 ± 10.2 (0-38) mo	15	6-mo dysfunction rate: 8.1%; 1-yr dysfunction rate: 20.1%; 2-yr dysfunction rate: 24.1%	27	35
Maleux et al[75]	2000.8-2003.5	56	Upper variceal bleeding (18), refractory ascites (23), variceal bleeding with refractory ascites (10), refractory ascites with hydrothorax (4), hydrothorax (1)	CPC A/B/C: 8/13/35	337 (4-962) d	1	NA	10	30-d: 3; overall: 16
Charon et al[76]	2000.7-2003.1	100	Variceal bleeding (81), refractory ascites (19)	CPC A/B/C: 20/46/34	261 (45-837) d	11	1-yr patency rate: 84%	Acute: 13	45
Hausegger et al[77]	1999.9-2002.3	71	Refractory ascites (44), recurrent esophageal bleeding (27)	CPC A/B/C: 10/43/18	NA	9	6-mo patency rate: 87.4%; 1-yr patency rate: 80.8%	18	30-d: 7; overall: 20

¹Data are expressed as absolute mean ± SD (range) or mean (range). BCS: Budd-Chiari syndrome; CPC: Child-Pugh class; HE: Hepatic encephalopathy; MELD: Model for end-stage liver disease; NA: Not available.